Differential activation of the integrated stress response correlates with anti -tumor activity of imipridones ONC201 and ONC206 in pediatric sarcomas

被引:0
|
作者
Allegakoen, David V. [1 ]
Tarapore, Rohinton S. [2 ]
Allen, Joshua E. [2 ]
Sabnis, Amit J. [1 ]
Bivona, Trever G. [1 ]
机构
[1] UCSF, San Francisco, CA USA
[2] Oncoceutics Inc, Philadelphia, PA USA
关键词
D O I
10.1158/1538-7445.AM2019-2664
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2664
引用
收藏
页数:2
相关论文
共 33 条
  • [1] MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206
    Prabhu, Varun
    Cuoco, Caroline
    Jung, Jinkyu
    Morrow, Sara
    Kawakibi, Abed Rahman
    Willette, Blair
    Day, Marilyn
    Anantharaman, Lakshmi
    Charter, Neil
    Rucker, Joseph
    Doranz, Benjamin
    Basken, Joel
    Stogniew, Martin
    Gilbert, Mark
    Free, R.
    Sibley, David
    Allen, Joshua
    NEURO-ONCOLOGY, 2020, 22 : 68 - 68
  • [2] Impact of hypoxia on the integrated stress response activated by imipridones ONC201 and ONC206 in pediatric diffuse midline glioma cells
    Roady, Tyler J.
    Stubbs, Nolan
    Chen, Josephine
    Xia, Yutong
    Uruchurtu, Ashley Sanchez Sevilla
    Tian, Xiaobing
    Zhou, Lanlan
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2024, 84 (06)
  • [3] ClpP drives efficacy and mediates acquired resistance with imipridones ONC201 and ONC206 in glioma in vitro
    Maranto, Cristina
    Foster, Scott
    Lee, Andrew
    Sethna, Phiroze
    Allen, Joshua E.
    Prabhu, Varun V.
    CANCER RESEARCH, 2024, 84 (05)
  • [4] Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
    Zhang, Yiqun
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Role of ClpP in the anti-cancer effects of imipridone ONC201 and ONC206
    Lee, Andrew
    Maranto, Cristina
    Foster, Scott
    Morrow, Sara
    Allen, Joshua E.
    Lanier, Randall
    Sethna, Phiroze
    Prabhu, Varun V.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] ONC201 AND ONC206 TARGET TUMOR CELL METABOLISM IN PEDIATRIC DIFFUSE MIDLINE GLIOMA PRECLINICAL MODELS
    Przystal, Justyna M.
    Cosentino, Chiara Cianciolo
    Yadavilli, Sridevi
    Zhang, Jie
    Laternser, Sandra
    Bonner, Erin R.
    Biery, Matt
    Vitanza, Nicholas A.
    Koschmann, Carl
    Cain, Jason
    Waszak, Sebastian M.
    Mueller, Sabine
    Nazarian, Javad
    NEURO-ONCOLOGY, 2021, 23 : 23 - 24
  • [7] A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins
    El-Soussi, Sarra
    Hanna, Reine
    Semaan, Hanna
    Khater, Amanda-Rose
    Abdallah, Jad
    Abou-Kheir, Wassim
    Abou-Antoun, Tamara
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [8] Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells
    Zhang, Yiqun
    Tapinos, Nikos
    Lulla, Rishi
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05):
  • [9] ROLE OF CLPP AND MITOCHONDRIAL METABOLISM IN THE ANTI-CANCER EFFECTS OF IMIPRIDONE ONC201 AND ONC206 IN GLIOBLASTOMA AND DIPG
    Foster, Scott
    Lee, Andrew
    Maranto, Cristina
    Allen, Joshua E.
    Lanier, Randall
    Sethna, Phiroze
    Prabhu, Varun V.
    NEURO-ONCOLOGY, 2022, 24 : 234 - 234
  • [10] Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines
    Purcell, Connor
    Srinivasan, Praveen R.
    Pinho-Schwermann, Maximilian
    Macdonald, William J.
    Ding, Elizabeth
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (12): : 7972 - 7982